Search results for "Highlights"
Sodium polystyrene sulfonate associated with GI events requiring hospitalization in elderly
An accompanying editorial said that based on the risk of gastrointestinal (GI) events found in this retrospective study, sodium polystyrene sulfonate should not be used to reduce serum potassium levels.
https://gastroenterology.acponline.org/archives/2019/06/28/2.htm
28 Jun 2019
Two-year results show continued benefit of phone or web CBT for refractory IBS
Patients with irritable bowel syndrome (IBS) who had been randomized to receive remote cognitive behavioral therapy (CBT) had lower symptom severity scores than those who had received usual care, according to follow-up data from a British trial.
https://gastroenterology.acponline.org/archives/2019/09/27/3.htm
27 Sep 2019
Efficacy, safety of second-line therapies analyzed for two types of IBS
A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.
https://gastroenterology.acponline.org/archives/2019/04/26/2.htm
26 Apr 2019
Fatty liver disease associated with increased risk of COVID-19 infection, hospitalization
However, patients who were obese but did not have fatty liver disease were not at increased risk of hospitalization for COVID-19, according to a study of healthy people in a U.K. database who underwent MRI assessment of liver fat markers.
https://gastroenterology.acponline.org/archives/2021/04/23/1.htm
23 Apr 2021
Spotlight on esophageal adenocarcinoma
High-dose proton-pump inhibitors and aspirin appeared effective for chemoprevention in patients with Barrett's esophagus in one study, while another study found a positive association between human papillomavirus status and survival in patients with Barrett's high-grade dysplasia and esophageal adenocarcinoma.
https://gastroenterology.acponline.org/archives/2018/08/24/5.htm
24 Aug 2018
Weight loss interventions may improve biomarkers of liver disease in NAFLD
In a meta-analysis of 22 studies in patients with nonalcoholic fatty liver disease (NAFLD), weight loss interventions were associated with improvements in alanine aminotransferase level, liver steatosis, histologic NAFLD activity score, and nonalcoholic steatohepatitis.
https://gastroenterology.acponline.org/archives/2019/07/26/3.htm
26 Jul 2019
Hepatitis A infections nearly triple, with some states seeing 5-fold increase, CDC says
The increase primarily occurred among people who reported drug use or homelessness.
https://gastroenterology.acponline.org/archives/2019/05/24/2.htm
24 May 2019
Study finds higher proportion of CRC diagnoses in patients under 50 since 2004
Based on the results, study authors suggested expanding colorectal cancer (CRC) screening to patients 45 years of age, but an accompanying editorial expressed concern that the risks could outweigh the benefits in the general population.
https://gastroenterology.acponline.org/archives/2019/07/26/2.htm
26 Jul 2019
Semaglutide showed some benefit in patients with NASH, liver fibrosis
Significantly more patients taking the glucagon-like peptide-1 receptor agonist had resolution of their nonalcoholic steatohepatitis (NASH) than those taking placebo, but rates of liver fibrosis improvement were similar between groups, an industry-funded trial found.
https://gastroenterology.acponline.org/archives/2020/11/20/1.htm
20 Nov 2020
Antidepressants and psychological therapies reduce IBS symptoms, meta-analysis finds
Psychological therapies were effective for irritable bowel syndrome (IBS) when delivered in person, whereas therapy that was self-administered, internet-based, or provided with minimal contact did not yield significant benefit.
https://gastroenterology.acponline.org/archives/2018/09/28/2.htm
28 Sep 2018